Written by:Fact check:

Overview

Lymphocytic Leukemia Overview

Lymphocytic leukemia is a cancer of lymphocytes, a type of white blood cell that helps the immune system fight infection. This page focuses on chronic lymphocytic leukemia (CLL), in which abnormal B lymphocytes can build up in the blood, bone marrow, lymph nodes, and spleen. CLL is most common in older adults and often develops slowly. It is different from acute lymphoblastic leukemia, which is a separate, usually faster-growing cancer involving immature lymphoid cells.

Symptoms

Symptoms of Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia may cause no symptoms at first and is sometimes found during a routine complete blood count. When symptoms occur, they can result from changes in blood-cell levels, a weakened immune system, or enlarged lymphatic organs. These signs do not confirm leukemia, so persistent or concerning symptoms should be evaluated by a healthcare professional.

  • Swollen lymph nodes (lymphadenopathy) may appear as painless lumps in the neck, armpits, or groin.
  • Unusual tiredness may occur because of anemia or the effects of the disease.
  • Repeated infections can happen when abnormal lymphocytes interfere with normal immune function.
  • Fever without a clear infection may be a sign of active disease or another medical problem.
  • Night sweats may soak clothing or bedding and occur without a warm room or heavy blankets.
  • Unexplained weight loss can occur without changes to diet or exercise.
  • Easy bruising or bleeding may result from a low platelet count.
  • Fullness under the ribs may occur when the spleen becomes enlarged.

Causes

Causes of Chronic Lymphocytic Leukemia

CLL begins when acquired genetic changes cause B lymphocytes to survive longer than they should or multiply abnormally. These cells can accumulate in the blood, bone marrow, lymph nodes, and spleen, interfering with normal blood-cell production and immune function. The exact cause of most cases is unknown, and CLL is not caused by anything a person did. It is generally not inherited in a simple, predictable pattern, although some families have a higher risk of CLL or related B-cell disorders.

Risk Factors

Risk Factors for Lymphocytic Leukemia

Established associations

Risk is higher with older age, and CLL is diagnosed more often in males. A close family history of CLL or a related B-cell disorder is also associated with increased risk. CLL also shows ethnic and geographic patterns, occurring more often in people of European ancestry and less often in some Asian populations.

Not a proven cause

Ordinary lifestyle choices have not been shown to reliably cause or prevent CLL. Having a risk factor does not mean a person will develop the disease, and people without known risk factors can still develop CLL.

Side Effects & Complications

Side Effects and Complications

Complications of CLL

  • Recurrent or severe infections can occur when CLL weakens normal immune defenses.
  • Anemia can cause tiredness, weakness, shortness of breath, or dizziness.
  • Low platelet levels can lead to easy bruising, nosebleeds, or other bleeding.
  • Enlarged lymph nodes or spleen can cause lumps, abdominal fullness, or discomfort.
  • Autoimmune destruction of blood cells can worsen anemia or reduce platelet levels.
  • Transformation to a more aggressive lymphoma can occur rarely and requires prompt specialist assessment.
  • Progression or resistance to treatment may require a change in the treatment plan.

Treatment-related considerations

Chemotherapy, targeted medicines, immunotherapy, and other leukemia treatments can cause fatigue, nausea, lowered blood counts, infections, or infusion reactions. Depending on the medicine, treatment may also affect heart rhythm or bleeding risk. The oncology team can explain prevention, monitoring, medicine interactions, and which symptoms require urgent care.

Diagnosis & Staging

Diagnosis and Staging

Doctors begin with a medical history and physical examination, including a check for enlarged lymph nodes, liver, or spleen. A complete blood count measures blood-cell levels, and a blood smear allows the cells to be examined under a microscope. Flow cytometry can identify abnormal B cells and help confirm CLL, while selected genetic or molecular tests help assess disease biology and treatment choices. Bone marrow testing, imaging, or lymph-node evaluation may be considered when the diagnosis is uncertain or more information is needed; CLL and small lymphocytic lymphoma are closely related but are classified mainly by where the abnormal lymphocytes are concentrated.

How CLL is classified and staged

Disease categoryTypical findingsManagement focus
Early or lower-riskLimited disease burden and no major symptomsObservation with scheduled monitoring is often considered
Intermediate-riskMore extensive lymph-node or blood involvement, with variable symptomsMonitor closely and consider treatment when disease becomes active or symptomatic
Advanced or higher-riskSignificant anemia, low platelets, enlarged organs, progressive disease, or troublesome symptomsActive treatment is more likely, guided by disease biology and overall health

Treatment Options

Treatment Options

Observation and supportive care

People with early, slow-growing, or symptom-free CLL may be monitored with examinations and blood tests rather than treated immediately. This approach is often called active observation or watchful waiting and does not mean care is being withheld. Supportive care may include infection prevention, appropriate vaccinations, treatment of anemia or bleeding, and management of symptoms.

Active treatment modalities

Active leukemia treatment may include targeted therapies, such as BTK or BCL2 inhibitors, that act on pathways important to CLL cells. Monoclonal antibodies and other immunotherapies help the immune system recognize or attack abnormal cells, while chemotherapy may be appropriate in selected situations. Stem-cell transplantation or cellular approaches may be considered for some people with high-risk or treatment-resistant disease. The choice depends on symptoms, genetic findings, previous treatment, age, other health conditions, and personal preferences.

Outlook and Prognosis

Outlook and Prognosis

CLL often follows a slow, variable course and may be managed for years, but some forms progress more quickly or become resistant to treatment. Prognostic factors include symptoms, blood counts, lymph-node or spleen involvement, genetic and molecular findings, response to treatment, age, and overall health. Chronic leukemia can therefore have very different effects from one person to another. Published survival statistics describe groups of people and cannot predict an individual person’s outcome.

Survivorship & Follow-up

Survivorship and Follow-Up

Follow-up for chronic lymphocytic leukemia is individualized and may include regular visits, blood counts, physical examinations, and symptom reviews. Repeat molecular or imaging tests may be used when the clinical situation calls for them. Ongoing care monitors progression, recurrence, treatment resistance, second cancers, infections, low blood counts, and delayed treatment effects.

  • Keep scheduled hematology appointments and blood tests.
  • Report persistent fever, new infections, unusual bleeding, or rapidly enlarging lymph nodes.
  • Review vaccines and infection-prevention measures with the care team.
  • Discuss fatigue, emotional health, sleep, and return to daily activities.
  • Keep an updated list of medicines, supplements, and prior CLL treatments.
  • Ask whether a written survivorship or long-term follow-up plan is appropriate.

Branches

2 topics

Tests & Procedure

5 topics